A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Feb 2012 Actual patient number is 19 according to ClinicalTrials.gov.
- 02 Feb 2012 Planned end date changed from 1 Jan 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.